NCT01458041View on ClinicalTrials.gov

Iloprost Therapy in Patients With Critical Limb Ischemia

CompletedOBSERVATIONAL

Enrollment

126

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

December 31, 2014

Conditions

Peripheral Arterial Disease

Interventions

DRUG

Iloprost (Ilomedin, BAYQ6256)

Prescription and treatment of Iloprost will be decided by physicians

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY